chronic plaque type psoriasis
Narrow Band UVB and PUVA Therapy: A Comparative study in patients with chronic plaque type psoriasis
... This is to certify that the dissertation titled “ NARROW BAND UVB AND PUVA THERAPY, A COMPARATIVE STUDY IN PATIENTS WITH CHRONIC PLAQUE TYPE PSORIASIS” submitted by Dr. A.MEKALA, in partial ...
78
Comparative study of therapeutic efficacy of PUVA, NBUVB and PUVASOL in the treatment of chronic plaque type psoriasis
... OF CHRONIC PLAQUE TYPE PSORIASIS ” is a bonafide work done by me at Madras Medical College during 2010-2013 under the guidance and supervision of ...
130
Narrowband UVB Versus Narrowband P-UVB in cases of Chronic Plaque type Psoriasis: A Matched pair study
... important mechanism of action is apoptosis of memory-effector CD45RO- positive T cells in the skin. 20% of patients achieve a 75% reduction in PASl (PASI 75) after a 12-week cycle of weekly intramuscular injections of ...
88
A CLINICAL STUDY TO EVALUATE THE EFFECT OF TOPICAL TAZAROTENE IN THE TREATMENT OF PLAQUE TYPE PSORIASIS IN A TERTIARY CARE HOSPITAL
... of plaque type psoriasis but however previous studies have shown reduced effect and severe irritation as side effect (Marks R et al, ...in chronic plaque psoriasis is still not ...
5
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
... Abstract: Chronic plaque psoriasis presents clinically as an inflammatory disease of the skin, which is often associated with comorbidities and responsible for a poor quality of ...onset, type ...
8
Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy
... Abstract: Psoriasis is a chronic inflammatory disease affecting up to 3% of the general population, associated with discomfort and impaired quality of ...of psoriasis has been extensively studied ...
9
REVIEW ARTICLE ----- CONCEPT OF EKAKUSHTA AND CHRONIC PLAQUE PSORIASIS ----- Gajanana Hegde, Noushad Khan
... another type of Kushta namely Kshwitra (Leucoderma) and its different types are explained in Ayurveda, on the contrary Ayurveda also considers skin diseases are ...of chronic plaque ...
12
Etanercept in psoriasis: the evidence of its therapeutic impact
... a chronic inflammatory skin condition that affects about 2% of the population (Pardasani et ...fact, psoriasis has been reported to cause greater physical and mental distress compared with many other major ...
12
Plaque Psoriasis: Understanding Risk Factors of This Inflammatory Skin Pathology
... Chronic plaque psoriasis is characterized by well-defined contour plaques, covered with whitish scaly skin, and which are most commonly found on the elbows, knees, lumbosacral area and scalp ...of ...
14
Infliximab in the treatment of plaque type psoriasis
... Abstract: Psoriasis is a chronic and immunomediated skin disease characterized by erythematous scaly ...plaques. Psoriasis affects approximately 1% to 3% of the Caucasian ...of plaque ...
12
Efficacy and safety of ustekinumab in adolescents
... of psoriasis that, although not unique to the pediatric population, are of special ...concern. Psoriasis can be very disfiguring, especially because the affected areas are often exposed, causing children to ...
12
Vol 26, No 2 (2016)
... A total of 30 patients with childhood psoriasis were evaluable. Median age of presentation was 8 years in our study whereas most of the patients presented within a range of 6-10 years. This is close to the ranges ...
5
Tacrolimus for the management of psoriasis: clinical utility and place in therapy
... In 2015, research was carried out to investigate the efficacy and safety of oral tacrolimus treatment in adults with severe recalcitrant psoriasis. The open-label prospective study included 30 patients who had ...
11
Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
... Abstract: Plaque psoriasis is an immune-mediated skin disease that affects roughly 3% of adults in the United ...of psoriasis have led to the development of targeted biologic therapies for this ...of ...
10
Vol 29, No 2 (2019)
... severe psoriasis had increased TSH levels and positive thyroid ...that psoriasis patients have hypothyroidism more commonly than ...in psoriasis and PsA ...
6
Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
... of psoriasis and other inflammatory diseases has created new chances for the development of targeted drug ...of plaque psoriasis in Phase III clinical ...for psoriasis treatment by regulatory ...
7
<p>Spotlight on itolizumab in the treatment of psoriasis – current perspectives from India</p>
... blind, placebo-controlled, parallel-arm, one-way crossover, multicentric, randomized withdrawal, phase III study of 225 patients with moderate-to-severe plaque psoriasis (PASI ≥ 10), the patients were ...
9
Emerging treatments in the management of psoriasis: biological targeting with ustekinumab
... The use of a single cytokine as a potential target of antipsoriatic treatment has been widely validated with the success of the anti-TNF a therapies. In fact fusion proteins (etanercept) or antibodies (inliximab, ...
9
Drug-induced psoriasis: clinical perspectives
... drug-related psoriasis are mostly lacking, traditionally strong associations have been documented for beta-blockers, lithium, antimalarial drugs such as (hydroxy)chloroquine, interferons, imiquimod, and ...
8
PubMedCentral-PMC5481723.pdf
... IL-1 is a prototypic pro-inflammatory cytokine that shares many properties with TNF-α and consists of 2 forms, IL-1α and IL-1β, the main biologically active form being IL-1β. Secretion of IL-1β is tightly regulated and ...
20